News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Quintiles, Inc. (Q) Announces Exercise Of The Underwriters' Option To Purchase Additional Secondary Shares


3/27/2014 9:30:03 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles today announced that the underwriters of the previously announced secondary public offering of 15 million shares of its common stock have exercised in full their option to purchase an additional 2.25 million shares from certain shareholders of Quintiles. After giving effect to the sale of the additional shares, which was completed on March 26, 2014, the selling shareholders sold a total of 17,250,000 shares of Quintiles’ common stock in the offering at a price to the public of $52.00 per share.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES